Knee osteoarthritis autoblood treatment method
Through self-healing treatment, centrifugation technology is used to separate platelet-rich plasma and inject it into the knee joint cavity with biocompatible materials, which solves the problem that existing knee osteoarthritis treatment is difficult to achieve long-term results and achieves effective repair of the knee joint and regeneration, improving therapeutic effect and safety.
Patent Information
- Application Number
- CN202411114006.1
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-14
- Publication Date
- 2024-11-22
- Estimated Expiration
- Not applicable · inactive patent
AI Technical Summary
Existing knee osteoarthritis treatment methods such as drug treatment, physical therapy and surgical treatment are difficult to achieve long-term and fundamental effects, and the preparation and application methods of platelet-rich plasma still need to be improved in terms of ease of operation, preparation efficiency and treatment effect.
The self-health treatment method is adopted to collect whole blood from the patient's peripheral vein, separate platelet-rich plasma through centrifugation, and combine biocompatible materials to directly inject into the knee joint cavity, and combine physical therapy to perform multiple injections. and perform appropriate rehabilitation exercises and monitoring.
Provide personalized treatment plans based on their own blood components, effectively promote the repair and regeneration of damaged tissues in the knee joint, improve treatment effect, reduce pain, improve knee joint function, and have high safety and short recovery time.
Smart Images

Figure CN118987029A_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to the technical field of biological treatment, and more specifically, to an autohemotherapy method for knee osteoarthritis. Background Art
[0002] Osteoarthritis, especially knee osteoarthritis, is a common degenerative bone and joint disease with a high incidence rate and serious impact on patients' daily activities and quality of life. Currently, although traditional treatments such as medication, physical therapy and surgery can relieve symptoms, they are often difficult to achieve long-term and fundamental therapeutic effects.
[0003] 1. Drug treatment: Commonly used nonsteroidal anti-inflammatory drugs and analgesics can relieve pain and inflammation, but long-term use may cause side effects such as gastrointestinal damage and kidney damage;
[0004] 2. Physical therapy: including heat therapy, cold therapy, electrotherapy, massage, etc. These treatments are mainly used to relieve pain and improve joint function, but the effects are usually temporary and require continuous treatment;
[0005] 3. Surgical treatment: In severe stages of the disease, arthroscopic surgery, cartilage transplantation or total knee replacement may be required. These surgeries are high-risk, require a long recovery time, and impose a greater physical and psychological burden on the patient.
[0006] In recent years, with the rapid development of regenerative medicine and tissue engineering technology, platelet-rich plasma therapy, as an emerging non-surgical treatment method, has gradually attracted widespread attention and shown good application prospects.
[0007] However, the existing methods for preparing and applying platelet-rich plasma still need to be improved in terms of ease of operation, preparation efficiency and therapeutic effect.
[0008] In view of this, the present invention proposes an autohemotherapy method for knee osteoarthritis. Summary of the invention
[0009] In order to overcome the above-mentioned defects of the prior art, the present invention provides an autohemotherapy method for knee osteoarthritis to solve the problems raised in the above-mentioned background technology.
[0010] To achieve the above object, the present invention provides the following technical solution: an autohemotherapy method for knee osteoarthritis, the method specifically comprising the following steps:
[0011] S1. Blood collection: a certain amount of whole blood is drawn from a peripheral vein of a patient with knee osteoarthritis, and the whole blood volume is sufficient for subsequent preparation of platelet-rich plasma;
[0012] S2. Plasma separation: placing the whole blood collected in step S1 in a platelet-rich plasma preparation device, separating the whole blood into a plasma layer, a white blood cell layer, a platelet layer and a red blood cell layer by centrifugation technology, collecting platelet-rich plasma with a platelet concentration significantly higher than that of normal plasma, and adjusting the pH value to 7.35-7.45;
[0013] S3, injection treatment: prepare biocompatible materials, and under aseptic operation conditions, inject the platelet-rich plasma and the prepared biocompatible materials prepared in step S2 directly into the patient's knee joint cavity through a syringe, wherein the injection amount is determined according to the patient's specific situation and the doctor's advice, and the injection method is divided into two types: mixed injection and sequential injection;
[0014] S4. Follow-up treatment: according to the patient's treatment response and the doctor's advice, multiple injections can be performed within one course of treatment, with a certain interval between each injection, and combined with physical therapy to enhance the therapeutic efficacy of the autologous blood components;
[0015] S5. Care and monitoring: guide patients to take appropriate rest and rehabilitation exercises after injection, regularly monitor the patient's knee joint condition, and adjust the treatment plan based on feedback.
[0016] Preferably, in step S1, the volume of whole blood is usually 20-30 ml, which is sufficient to meet the needs of one treatment.
[0017] Preferably, in step S2, the centrifugation technique includes but is not limited to gradient centrifugation, isopycnic centrifugation or time gradient centrifugation to optimize the preparation effect of platelet-rich plasma;
[0018] Wherein, the steps of gradient centrifugation are:
[0019] Add an appropriate amount of separation solution to the bottom of the centrifuge tube, then gently dilute the anticoagulated whole blood with phosphate buffer or other buffer, and slowly add it into the centrifuge tube along the tube wall so that the whole blood covers the separation solution;
[0020] Place the centrifuge tube in a centrifuge and centrifuge at 2000-3000 rpm for 20-30 minutes. During the centrifugation process, the components in the blood will be separated into layers according to the density gradient due to the difference in density.
[0021] After centrifugation, the centrifuge tube can be seen to be divided into clear layers, among which the platelet layer will be located in a certain density range. Use a pipette or a pipette to carefully suck out the platelet-rich plasma in this layer;
[0022] The steps of isopycnic centrifugation are:
[0023] Choose sucrose or polysucrose as the medium and adjust its density to be close to that of platelets by adding or removing solutes;
[0024] After the medium with adjusted density is mixed with whole blood, anticoagulants, stabilizers or substances that promote the release of growth factors from platelets are added, and the mixture is placed in a centrifuge and centrifuged at 1500-2000 rpm for 15-20 minutes;
[0025] After centrifugation, the target component will precipitate at the bottom of the tube or form a suspension band, which can be collected by appropriate methods;
[0026] The steps of time gradient centrifugation are:
[0027] The initial centrifugation is performed at 600-800 rpm for 8-10 min to allow most of the red blood cells and white blood cells to settle, while platelets and plasma remain in the upper layer;
[0028] The upper layer of liquid was transferred to a new centrifuge tube and centrifuged at 1500-2000 rpm for 15-20 min for a second time to further enrich platelets;
[0029] After secondary centrifugation, the upper layer is the platelet-rich plasma that needs to be collected.
[0030] Preferably, in step S3, the injection treatment also includes the steps of cleaning and disinfecting the knee joint cavity before injection to ensure the sterility of the injection process.
[0031] Preferably, in step S3, the biocompatible material includes but is not limited to biodegradable gels, microparticles or microspheres, hydrogel microspheres and nanofibers, wherein the biodegradable gel includes a gel based on hyaluronic acid, collagen or fibrin, the microparticles or microspheres include but are not limited to polylactic acid or polylactic acid-co-glycolic acid microparticles, the hydrogel microspheres are microspheres with a high water content, and the nanofibers are nanofibers produced by electrospinning.
[0032] Preferably, in step S3, the mixed injection is to first mix the biocompatible material with the platelet-rich plasma to form a complex or solution, and then inject it to optimize its performance and activity in vivo;
[0033] The sequential injection is to first inject a scaffold made of biocompatible materials, and then inject platelet-rich plasma or tissue fluid rich in cells to promote tissue regeneration and repair.
[0034] Preferably, in step S4, the rehabilitation exercises include but are not limited to joint range of motion training, muscle strength training and balance training, aiming to promote the full recovery of knee joint function, and the physical therapy includes a low-intensity pulsed ultrasonic generator for providing ultrasonic stimulation.
[0035] Preferably, in step S2, the preparation device includes a centrifuge, a blood collection container, a plasma separation tube and a platelet collection tube, wherein the centrifuge is used to centrifuge the blood, the blood collection container is used to collect whole blood drawn from the patient, the plasma separation tube is used to separate the plasma layer, and the platelet collection tube is used to collect platelet-rich plasma.
[0036] Preferably, the preparation device also includes a sterile operation interface and a filter to ensure the sterility and purity of the plasma during the preparation process.
[0037] Technical effects and advantages of the present invention:
[0038] 1. The present invention collects blood from the patient's own peripheral veins and prepares platelet-rich plasma, providing the patient with a personalized treatment plan based on his own blood components. Platelet-rich plasma is rich in growth factors and repair factors, which can effectively promote the repair and regeneration of damaged tissues in the knee joint, thereby improving the treatment effect. At the same time, the injection amount and injection method are determined according to the patient's specific situation and the doctor's advice to ensure the pertinence and effectiveness of the treatment;
[0039] 2. The present invention combines biocompatible materials, such as biodegradable gels, microparticles or microspheres, in the process of injection therapy. These materials not only have good biocompatibility, but can also serve as carriers or scaffolds to promote the retention and release of growth factors in platelet-rich plasma in tissues, thereby further enhancing the therapeutic effect. In addition, through mixed injection or sequential injection, the distribution and performance of platelet-rich plasma and biocompatible materials in the body can be optimized to promote the regeneration and repair of knee joint tissues. BRIEF DESCRIPTION OF THE DRAWINGS
[0040] Figure 1 It is the overall flow chart of the present invention. DETAILED DESCRIPTION
[0041] Example 1: Single centrifugation combined with mixed injection to treat knee osteoarthritis
[0042] This embodiment provides an autohemotherapy method for knee osteoarthritis, which specifically includes the following steps:
[0043] S1. Blood collection: 20-30 ml of whole blood is drawn from the patient's peripheral vein (such as the cubital vein) using a blood collection tube containing an anticoagulant;
[0044] S2, plasma separation, preparing a platelet-rich plasma preparation device, including a centrifuge, a blood collection container, a plasma separation tube and a platelet collection tube, as well as a sterile operation interface and a filter;
[0045] Centrifugal separation;
[0046] Gradient centrifugation method: add an appropriate amount of separation liquid (such as Ficoll) to the bottom of the centrifuge tube, dilute the anticoagulated whole blood with phosphate buffer, and slowly add it to the centrifuge tube along the tube wall. Place the centrifuge tube in a centrifuge and centrifuge at 2500rpm for 25min. Use a pipette to carefully aspirate the platelet-rich plasma layer in a specific density range, and adjust the collected platelet-rich plasma to a pH of 7.35-7.45 with an appropriate buffer.
[0047] S3, injection treatment: according to the needs, choose hyaluronic acid gel, clean and disinfect the knee joint cavity under aseptic conditions, mix the hyaluronic acid gel and platelet-rich plasma evenly, and inject it directly into the knee joint cavity through a syringe. Each injection should not exceed 5ml;
[0048] S4. Follow-up treatment: Based on the patient's treatment response and the doctor's advice, multiple injections can be performed within one course of treatment, with a certain interval between each injection (e.g. once a week), combined with physical therapy such as low-intensity pulsed ultrasound to enhance the treatment effect;
[0049] S5. Nursing and monitoring: guide patients to take appropriate rest and rehabilitation exercises, including joint range of motion training, muscle strength training and balance training, regularly monitor the patient's knee joint condition, evaluate the treatment effect, and adjust the treatment plan based on feedback.
[0050] Example 2: Treatment of knee osteoarthritis by isopycnic centrifugation combined with sequential injections
[0051] This embodiment provides an autohemotherapy method for knee osteoarthritis, which specifically includes the following steps:
[0052] S1. Blood collection: 20-30 ml of whole blood is drawn from the patient's peripheral vein (such as the cubital vein) using a blood collection tube containing an anticoagulant;
[0053] S2, plasma separation, preparing a platelet-rich plasma preparation device, including a centrifuge, a blood collection container, a plasma separation tube and a platelet collection tube, as well as a sterile operation interface and a filter;
[0054] Centrifugal separation;
[0055] Isopycnic centrifugation method: sucrose or polysucrose is selected as the medium, and its density is adjusted by adding or removing solutes to make it close to the density of platelets. After the medium with adjusted density is mixed with whole blood, anticoagulants, stabilizers or substances that promote the release of growth factors from platelets are added, and the medium is placed in a centrifuge and centrifuged at 1500 rpm for 15 minutes. After centrifugation, the target component will precipitate at the bottom of the tube or form a suspension band, which can be collected by appropriate methods.
[0056] S3, injection therapy, under sterile conditions, first inject a fibrin-based microparticle scaffold into the knee joint cavity, and then inject platelet-rich plasma rich in growth factors to promote tissue repair;
[0057] S4. Follow-up treatment: Based on the patient's treatment response and the doctor's advice, multiple injections can be performed within one course of treatment, with a certain interval between each injection (e.g. once a week), combined with physical therapy such as low-intensity pulsed ultrasound to enhance the treatment effect;
[0058] S5. Nursing and monitoring: guide patients to take appropriate rest and rehabilitation exercises, including joint range of motion training, muscle strength training and balance training, regularly monitor the patient's knee joint condition, evaluate the treatment effect, and adjust the treatment plan based on feedback.
[0059] Example 3: Treatment of knee osteoarthritis by time gradient centrifugation and hydrogel microsphere mixed injection
[0060] This embodiment provides an autohemotherapy method for knee osteoarthritis, which specifically includes the following steps:
[0061] S1. Blood collection: 20-30 ml of whole blood is drawn from the patient's peripheral vein (such as the cubital vein) using a blood collection tube containing an anticoagulant;
[0062] S2, plasma separation, preparing a platelet-rich plasma preparation device, including a centrifuge, a blood collection container, a plasma separation tube and a platelet collection tube, as well as a sterile operation interface and a filter;
[0063] Centrifugal separation;
[0064] Time gradient centrifugation method, centrifuge at 800rpm for 8min for the first centrifugation, so that most of the red blood cells and white blood cells are sedimented, while platelets and plasma are retained in the upper layer, then the upper layer liquid is transferred to a new centrifuge tube and centrifuged at 1500rpm for 20min for the second centrifugation to further enrich platelets. After the second centrifugation, the upper layer is the platelet-rich plasma that needs to be collected;
[0065] S3. Injection therapy: according to the needs, under sterile operating conditions, the high-water content hydrogel microspheres are mixed with platelet-rich plasma to form an injection solution, which is directly injected into the knee joint cavity through a syringe. Each injection should not exceed 5 ml.
[0066] S4. Follow-up treatment: Based on the patient's treatment response and the doctor's advice, multiple injections can be performed within one course of treatment, with a certain interval between each injection (e.g. once a week), combined with physical therapy such as low-intensity pulsed ultrasound to enhance the treatment effect;
[0067] S5. Nursing and monitoring: guide patients to take appropriate rest and rehabilitation exercises, including joint range of motion training, muscle strength training and balance training, regularly monitor the patient's knee joint condition, evaluate the treatment effect, and adjust the treatment plan based on feedback.
[0068] Example 4: Treatment of knee osteoarthritis by sequential injection of nanofiber scaffold and platelet-rich plasma
[0069] This embodiment provides an autohemotherapy method for knee osteoarthritis, which specifically includes the following steps:
[0070] S1. Blood collection: 20-30 ml of whole blood is drawn from the patient's peripheral vein (such as the cubital vein) using a blood collection tube containing an anticoagulant;
[0071] S2, plasma separation, preparing a platelet-rich plasma preparation device, including a centrifuge, a blood collection container, a plasma separation tube and a platelet collection tube, as well as a sterile operation interface and a filter;
[0072] Centrifugal separation: Platelet-rich plasma was prepared from 30 ml of whole blood using time gradient centrifugation;
[0073] S3, injection therapy, using electrospinning technology to make nanofiber scaffolds, and injecting nanofiber scaffolds and platelet-rich plasma into the patient's knee joint cavity under aseptic conditions as needed, where the nanofibers provide structural support and the platelet-rich plasma releases growth factors to promote cell proliferation;
[0074] S4. Follow-up treatment: Based on the patient's treatment response and the doctor's advice, multiple injections can be performed within one course of treatment, with a certain interval between each injection (e.g. once a week), combined with physical therapy such as low-intensity pulsed ultrasound to enhance the treatment effect;
[0075] S5. Nursing and monitoring: guide patients to take appropriate rest and rehabilitation exercises, including joint range of motion training, muscle strength training and balance training, regularly monitor the patient's knee joint condition, evaluate the treatment effect, and adjust the treatment plan based on feedback.
[0076] In order to prove that the above embodiment of the present invention has a good therapeutic effect on knee osteoarthritis, an experimental verification was conducted on the above embodiment, and the results are shown in the following table:
[0077] 1. Comparison of clinical effects: a randomized controlled trial was designed to randomly divide patients into two groups, one group receiving the treatment method of the present invention (treatment group), and the other group receiving current standard treatment or placebo treatment (control group). The pain and functional status of the patients were evaluated using the modified knee arthritis scale (KOOS) and visual analog pain scale (VAS) before treatment and at 3 months, 6 months and 1 year after treatment;
[0078] 2. Patient satisfaction survey: After the treatment, a satisfaction survey was conducted on the two groups of patients to understand their satisfaction with the treatment process, effect and recovery time;
[0079] 3. Recovery time statistics: record the recovery time of the two groups of patients, including the time to return to daily activities without painkillers and the time to return to normal knee joint function;
[0080] 4. Monitor and record adverse reactions and complications of the two groups of patients during the treatment.
[0081] index Method of the present invention (n=50) Conventional treatment methods (n=50) P-value KOOS score (March) 75±10 65±12 <0.05 KOOS score (June) 85±9 73±11 <0.01 KOOS score (1 year) 90±8 78±10 <0.001 VAS pain score (3 months) 3±2 4±2 <0.05 VAS pain score (6 months) 2±1 3±2 <0.01 VAS pain score (1 year) 1±1 2±2 <0.001 Satisfaction (%) 90% 75% <0.05 Average recovery time (days) 60 90 <0.001 Adverse reaction rate (%) 2% 5% <0.05
[0082] illustrate:
[0083] KOOS score: modified knee arthritis evaluation scale, the higher the score, the better the knee function;
[0084] VAS pain score: Visual Analogue Pain Scale, the lower the score, the less pain;
[0085] Satisfaction: The percentage of patients who are satisfied with the treatment process and results;
[0086] Mean recovery time: The average time required to return to normal knee function, in days;
[0087] Incidence of adverse reactions: the proportion of patients who experienced adverse reactions during treatment;
[0088] P value: the significance level of the difference between the treatment group and the control group;
[0089] n = sample size per group.
[0090] Based on the above table, it can be seen that, first of all, from the KOOS score, the method of the present invention is significantly higher than the conventional treatment method at each stage after treatment (3 months, 6 months, 1 year), which means that the knee joint function of patients using the method of the present invention is better restored and improved;
[0091] The VAS pain score showed that at all stages of treatment, the pain levels reported by patients using the method of the present invention were lower than those of patients receiving conventional treatment, which indicates that the present invention can more effectively reduce the pain of patients and improve their quality of life;
[0092] The satisfaction survey shows that 90% of the patients who used the method of the present invention were satisfied with the treatment results, which is higher than the 75% of conventional treatment methods. The high satisfaction rate reflects the patients' recognition of the treatment effect and their positive experience of the treatment process.
[0093] The average recovery time index shows that the time for patients using the method of the present invention to recover to normal knee joint function is 30 days faster than that of conventional treatment. The fast recovery time means that patients can return to daily life and work earlier, reducing the burden of life caused by the disease.
[0094] The incidence of favorable reactions is low. The incidence of adverse reactions of the method of the present invention is only 2%. In comparison, the incidence of adverse reactions of conventional treatment methods is 5%. The low incidence of adverse reactions indicates that the method of the present invention has better safety and less health risks to patients.
[0095] In summary, the autohemotherapy method for knee osteoarthritis of the present invention shows significant advantages in improving knee joint function, alleviating pain, improving patient satisfaction, accelerating recovery, and ensuring treatment safety. These advantages make it a more attractive treatment option and help improve the treatment effect and quality of life of patients.
[0096] The above description is only a preferred embodiment of the present invention and is not intended to limit the present invention. Any modifications, equivalent substitutions, improvements, etc. made within the spirit and principle of the present invention should be included in the protection scope of the present invention.
Claims
1. An autohemotherapy method for knee osteoarthritis, characterized in that: The method specifically comprises the following steps: S1. Blood collection: a certain amount of whole blood is drawn from a peripheral vein of a patient with knee osteoarthritis, and the whole blood volume is sufficient for subsequent preparation of platelet-rich plasma; S2, plasma separation, placing the whole blood collected in step S1 in a platelet-rich plasma preparation device, separating the whole blood into a plasma layer, a white blood cell layer, a platelet layer and a red blood cell layer by centrifugation technology, and collecting platelet-rich plasma with a platelet concentration significantly higher than that of normal plasma, and adjusting the pH value to 7.35-7.45; S3, injection treatment, prepare biocompatible materials, and under aseptic operation conditions, inject the platelet-rich plasma and the prepared biocompatible materials in step S2 directly into the patient's knee joint cavity through a syringe, wherein the injection amount is determined according to the patient's specific situation and the doctor's advice, and the injection method is divided into two types: mixed injection and sequential injection; S4. Follow-up treatment: according to the patient's treatment response and the doctor's advice, multiple injections can be performed within one course of treatment, with a certain interval between each injection, and combined with physical therapy to enhance the therapeutic efficacy of the autologous blood components; S5. Care and monitoring: guide patients to take appropriate rest and rehabilitation exercises after injection, regularly monitor the patient's knee joint condition, and adjust the treatment plan based on feedback.
2. The method for autohemotherapy of knee osteoarthritis according to claim 1, characterized in that: In step S1, the whole blood volume is usually 20-30 ml, which is sufficient to meet the needs of one treatment.
3. The method for autohemotherapy of knee osteoarthritis according to claim 1, characterized in that: In step S2, centrifugation techniques include but are not limited to gradient centrifugation, isopycnic centrifugation or time gradient centrifugation to optimize the preparation effect of platelet-rich plasma; Wherein, the steps of gradient centrifugation are: Add an appropriate amount of separation solution to the bottom of the centrifuge tube, then gently dilute the anticoagulated whole blood with phosphate buffer or other buffer, and slowly add it into the centrifuge tube along the tube wall so that the whole blood covers the separation solution; Place the centrifuge tube in a centrifuge and centrifuge at 2000-3000 rpm for 20-30 minutes. During the centrifugation process, the components in the blood will be separated into layers according to the density gradient due to the difference in density. After centrifugation, the centrifuge tube can be seen to be divided into clear layers, among which the platelet layer will be located in a certain density range. Use a pipette or a pipette to carefully suck out the platelet-rich plasma in this layer; The steps of isopycnic centrifugation are: Choose sucrose or polysucrose as the medium and adjust its density to be close to that of platelets by adding or removing solutes; After the medium with adjusted density is mixed with whole blood, anticoagulants, stabilizers or substances that promote the release of growth factors from platelets are added, and the mixture is placed in a centrifuge and centrifuged at 1500-2000 rpm for 15-20 minutes; After centrifugation, the target component will precipitate at the bottom of the tube or form a suspension band, which can be collected by appropriate methods; The steps of time gradient centrifugation are: The initial centrifugation is performed at 600-800 rpm for 8-10 min to allow most of the red blood cells and white blood cells to settle, while platelets and plasma remain in the upper layer; The upper layer of liquid was transferred to a new centrifuge tube and centrifuged at 1500-2000 rpm for 15-20 min for a second time to further enrich platelets; After secondary centrifugation, the upper layer is the platelet-rich plasma that needs to be collected.
4. The method for autohemotherapy of knee osteoarthritis according to claim 1, characterized in that: In step S3, the injection treatment also includes the steps of cleaning and disinfecting the knee joint cavity before injection to ensure the sterility of the injection process.
5. The method for autohemotherapy of knee osteoarthritis according to claim 1, characterized in that: In step S3, the biocompatible material includes but is not limited to biodegradable gels, microparticles or microspheres, hydrogel microspheres and nanofibers, wherein the biodegradable gel includes a gel based on hyaluronic acid, collagen or fibrin, the microparticles or microspheres include but are not limited to polylactic acid or polylactic acid-co-glycolic acid microparticles, the hydrogel microspheres are microspheres with a high water content, and the nanofibers are nanofibers produced by electrospinning.
6. The method for autohemotherapy of knee osteoarthritis according to claim 1, characterized in that: In step S3, the mixed injection is to first mix the biocompatible material with platelet-rich plasma to form a complex or solution, which is then injected to optimize its performance and activity in vivo; The sequential injection is to first inject a scaffold made of biocompatible materials, and then inject platelet-rich plasma or tissue fluid rich in cells to promote tissue regeneration and repair.
7. The method for autohemotherapy of knee osteoarthritis according to claim 1, characterized in that: In step S4, rehabilitation exercises include but are not limited to joint range of motion training, muscle strength training, and balance training, aiming to promote full recovery of knee joint function, and physical therapy includes a low-intensity pulsed ultrasound generator to provide ultrasonic stimulation.
8. The method for autohemotherapy of knee osteoarthritis according to claim 1, characterized in that: In step S2, the preparation device includes a centrifuge, a blood collection container, a plasma separation tube and a platelet collection tube, wherein the centrifuge is used to centrifuge the blood, the blood collection container is used to collect whole blood drawn from the patient, the plasma separation tube is used to separate the plasma layer, and the platelet collection tube is used to collect platelet-rich plasma.
9. The method for autohemotherapy of knee osteoarthritis according to claim 6, characterized in that: The preparation device also includes a sterile operation interface and a filter to ensure the sterility of the preparation process and the purity of the plasma.
